Benakor® 2.5 mg

Benakor causes long-lasting inhibition of plasma ACE activity in cats, thereby reducing the blood pressure and volume load on the hart and normalizing elevated glomerular capillary pressure and the systemic blood pressure. Reduction in glomerular hypertension retards the progression of kidney disease by inhibition of further damage to the kidneys.
Benakor is therefore indicated for the reduction of proteinuria associated with chronic kidney disease in cats.


Target species

Package size

Package of 2x14 or 7x14 tablets

Active substance

2.5 mg Benazepril hydrochloride tablets

Available for